BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19528469)

  • 1. Latrunculin a has a strong anticancer effect in a peritoneal dissemination model of human gastric cancer in mice.
    Konishi H; Kikuchi S; Ochiai T; Ikoma H; Kubota T; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Sonoyama T; Kokuba Y; Sasaki H; Matsui T; Otsuji E
    Anticancer Res; 2009 Jun; 29(6):2091-7. PubMed ID: 19528469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated transfection of caspase-8 augments anoikis and inhibits peritoneal dissemination of human gastric carcinoma cells.
    Nishimura S; Adachi M; Ishida T; Matsunaga T; Uchida H; Hamada H; Imai K
    Cancer Res; 2001 Oct; 61(19):7009-14. PubMed ID: 11585725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of intra-peritoneal and intra-venous injection of monoclonal antibody A7-NCS conjugates against peritoneal dissemination of the gastric cancer].
    Kuriu Y; Otsuji E; Okamoto K; Ichikawa D; Fujiwara H; Ochiai T; Sakakura C; Ueda Y; Sonoyama T; Hagiwara A; Yamagishi H
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1842-3. PubMed ID: 15553733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine kinase inhibitor SU6668 inhibits peritoneal dissemination of gastric cancer via suppression of tumor angiogenesis.
    Tokuyama J; Kubota T; Saikawa Y; Yoshida M; Furukawa T; Otani Y; Kumai K; Kitajima M
    Anticancer Res; 2005; 25(1A):17-22. PubMed ID: 15816514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The newly synthesized anticancer drug HUHS1015 is useful for treatment of human gastric cancer.
    Kaku Y; Tsuchiya A; Kanno T; Nakao S; Shimizu T; Tanaka A; Nishizaki T
    Cancer Chemother Pharmacol; 2015 Mar; 75(3):527-35. PubMed ID: 25567349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.
    Kinoshita J; Fushida S; Tsukada T; Oyama K; Watanabe T; Shoji M; Okamoto K; Nakanuma S; Sakai S; Makino I; Furukawa H; Hayashi H; Nakamura K; Inokuchi M; Nakagawara H; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fujimura T; Masakazu Y; Hirakawa K; Ohta T
    Oncol Rep; 2014 Jul; 32(1):89-96. PubMed ID: 24859429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intraoperative and postoperative intra-peritoneal administration of peptide PIII inhibits peritoneal metastasis of gastric cancer].
    Bai FH; Yang L; Ji Q; Zhang YQ; Liu ZX; Wang ZZ; Yan L; Wang JB; Jin HF; Li TT
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3260-3. PubMed ID: 17313805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice.
    Ohashi N; Kodera Y; Nakanishi H; Yokoyama H; Fujiwara M; Koike M; Hibi K; Nakao A; Tatematsu M
    Int J Oncol; 2005 Sep; 27(3):637-44. PubMed ID: 16077911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel intraperitoneal therapy for gastric cancer with DFP-10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model.
    Ando H; Fukushima M; Eshima K; Hasui T; Shimizu T; Ishima Y; Huang CL; Wada H; Ishida T
    Cancer Med; 2019 Dec; 8(17):7313-7321. PubMed ID: 31609087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of monoclonal antibody-neocarzinostatin conjugate for gastric cancer with peritoneal dissemination--comparison between early and late administration].
    Okamoto K; Otsuji E; Toma A; Kobayashi S; Kitamura K; Yamaguchi T; Yamagishi H
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1508-10. PubMed ID: 11707966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing a peritoneal dissemination xenograft mouse model for survival outcome assessment of experimental gastric cancer.
    Zhang C; Awasthi N; Schwarz MA; Schwarz RE
    J Surg Res; 2013 Jun; 182(2):227-34. PubMed ID: 23201270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer.
    Sako A; Kitayama J; Koyama H; Ueno H; Uchida H; Hamada H; Nagawa H
    Cancer Res; 2004 May; 64(10):3624-8. PubMed ID: 15150121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of latrunculin reveal requirements for the actin cytoskeleton during secretion from mast cells.
    Pendleton A; Koffer A
    Cell Motil Cytoskeleton; 2001 Jan; 48(1):37-51. PubMed ID: 11124709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis.
    Okazaki M; Fushida S; Harada S; Tsukada T; Kinoshita J; Oyama K; Miyashita T; Ninomiya I; Ohta T
    BMC Cancer; 2017 Jan; 17(1):23. PubMed ID: 28056854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kappaB activation in human gastric carcinoma cells.
    Nakahara C; Nakamura K; Yamanaka N; Baba E; Wada M; Matsunaga H; Noshiro H; Tanaka M; Morisaki T; Katano M
    Clin Cancer Res; 2003 Nov; 9(14):5409-16. PubMed ID: 14614027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugated linoleic acid inhibits peritoneal metastasis in human gastrointestinal cancer cells.
    Kuniyasu H; Yoshida K; Sasaki T; Sasahira T; Fujii K; Ohmori H
    Int J Cancer; 2006 Feb; 118(3):571-6. PubMed ID: 16106401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer.
    Miyake S; Kitajima Y; Nakamura J; Kai K; Yanagihara K; Tanaka T; Hiraki M; Miyazaki K; Noshiro H
    Int J Oncol; 2013 Nov; 43(5):1431-40. PubMed ID: 23970191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 may be effective against peritoneal dissemination in gastric cancer.
    Yamagata S; Nakata B; Hirakawa K
    Oncol Rep; 2004 Nov; 12(5):973-8. PubMed ID: 15492780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-VEGF therapy for peritoneal dissemination model of gastric cancer considering of pharmacokinetics].
    Yagi Y; Fushida S; Fujita H; Kinami S; Ninomiya I; Fujimura T; Kayahara M; Ohta T; Yashiro M; Hirakawa K
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2005-8. PubMed ID: 19106505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of natural polysaccharides on the growth and peritoneal carcinomatosis of human gastric adenocarcinoma in a nude mouse model.
    Bae JS; Jang KH; Jin HK
    Cancer Lett; 2006 Apr; 235(1):60-8. PubMed ID: 15899545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.